Planet UltraMarathon

Regular Cola Intake May Reduce Bone Mineral Density in Women

CME/CE

News Author: Laurie Barclay, MD
CME Author: Charles Vega, MD, FAAFP

Complete author affiliations and disclosures, and other CME information, are available at the end of this activity.

Release Date: October 11, 2006Valid for credit through October 11, 2007

Credits Available

Physicians - maximum of 0.25 AMA PRA Category 1 Credit(s) for physicians;
Family Physicians - up to 0.25 AAFP Prescribed credit(s) for physicians;
Nurses - 0.3 nursing contact hours (None of these credits is in the area of pharmacology)

All other healthcare professionals completing continuing education credit for this activity will be issued a certificate of participation.
Physicians should only claim credit commensurate with the extent of their participation in the activity.


October 11, 2006 — Regular consumption of carbonated cola drinks may increase risk for low bone mineral density (BMD) in women, according to the results of the Framingham Osteoporosis Study reported in the October issue of the American Journal of Clinical Nutrition.

"Soft drink consumption may have adverse effects on bone mineral density (BMD), but studies have shown mixed results," write Katherine L. Tucker, MD, from Tufts University in Boston, Massachusetts, and colleagues. "In addition to displacing healthier beverages, colas contain caffeine and phosphoric acid (H3PO4), which may adversely affect bone."

Using dual-energy x-ray absorptiometry, the investigators measured BMD at the spine and at 3 hip sites in 1413 women and in 1125 men in the Framingham Osteoporosis Study. Dietary intake was evaluated with a food frequency questionnaire. Each BMD measure was regressed on the frequency of soft drink consumption after adjustment for body mass index, height, age, energy intake, physical activity score, smoking, alcohol use, total calcium intake, total vitamin D intake, caffeine from noncola sources, season of measurement, and, for women, menopausal status and estrogen use.

Cola intake was associated with lower BMD at each hip site in women but not in men (P < .001 - .05). However, it was not linked with lower BMD at the spine for women or men. Compared with those who consumed less than 1 serving of cola per month, those with daily cola intake had a mean BMD 3.7% lower at the femoral neck and 5.4% lower at Ward's area. These results were similar with diet cola and to a lesser extent with decaffeinated cola.

There were no significant relationships between noncola carbonated beverage consumption and BMD. Although total phosphorus intake was not significantly higher in daily cola consumers than in nonconsumers, the calcium-to-phosphorus ratios were lower.

Study limitations include possibly incomplete control of confounding.

"Intake of cola, but not of other carbonated soft drinks, is associated with low BMD in women," the authors write. "Additional research is needed to confirm these findings.... Unless additional evidence rules out an effect, women who are concerned about osteoporosis may want to avoid the regular use of cola beverages."

The United States Department of Agriculture and the National Institutes of Health supported this study. The authors have disclosed no relevant financial relationships.

Am J Clin Nutr. 2006;84:936-942.

Learning Objectives for This Educational Activity

Upon completion of this activity, participants will be able to:
  • Describe possible mechanisms for a negative effect of cola on BMD.
  • Identify the risk for reduced BMD associated with cola intake among men and women.

Clinical Context

Increased cola intake has been demonstrated to reduce BMD in children, and several mechanisms may be responsible for this association. Caffeine is a defined risk factor for osteoporosis, and high fructose corn syrup may reduce bone density. In addition, colas contain phosphoric acid, which can reduce serum calcium levels and promote higher levels of parathyroid hormone. This hormone, in turn, can increase bone turnover and lead to osteoporosis.

The current cohort study examines the BMD in relation to cola intake among men and women.

Study Highlights

  • The study population was drawn from the Framingham Offspring Cohort. 5124 participants comprised the study cohort and were evaluated every 4 years with an extensive health history, physical examination, and laboratory evaluation. Dietary intake was evaluated with a validated 126-item questionnaire. Subjects also underwent dual-energy x-ray absorptiometry at the lumbar spine and hip between 1996 and 2001. The current analysis excluded subjects using medications, which could increase BMD, and those at the extremes of daily caloric intake.
  • The main study outcome was the relationship between BMD and intake of cola beverages. Results were adjusted for age, body mass index, height, smoking, and average daily consumption of alcohol, caffeine, and calcium. The authors also adjusted results for total energy intake and physical activity in both men and women as well as the presence of menopause and treatment with estrogen in women.
  • 2538 subjects had data for analysis. The mean age of participants was 59 years, and the mean body mass index was 28 kg/m2. Generally, participants tended to be overweight, ex-smokers, and moderate consumers of alcohol. Mean consumption of carbonated beverages was 6 servings per week among men and 5 servings per week among women. Average noncola carbonated beverage consumption was 1.5 servings per week, and diet cola intake accounted for approximately half of total cola consumption.
  • Noncola carbonated beverage intake did not affect BMD. Cola intake did not significantly affect the BMD of men.
  • While spine BMD was unaffected by cola intake among women, hip BMD was reduced in linear fashion with higher degrees of cola consumption. BMD was 3.8% lower when researchers compared women who consumed cola daily vs those who did not drink cola. Caffeinated cola had a greater effect in reducing hip BMD vs decaffeinated cola, although both types of beverage had significant effects. While sugared decaffeinated cola failed to achieve a significant effect at the hip, this cola was the least popular, and the association was probably underpowered.
  • Cola intake did not affect levels of milk consumption, although there was a negative relationship between cola intake and consumption of fruit juice and calcium. Reduced consumption of milk or fruit juice failed to fully explain the negative effects of cola on the hip BMD in women.

Pearls for Practice

  • Cola may reduce BMD through higher intake of caffeine, high fructose corn syrup, phosphoric acid, or some combination of these effects.
  • The current study demonstrates that higher degrees of cola consumption may be associated with reduced hip BMD among women. However, cola consumption did not affect BMD among men, and it failed to significantly reduce BMD in the lumbar spine in either sex.

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page.

FOLLOW THESE STEPS TO EARN CME/CE CREDIT*:
  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. Medscape encourages you to complete the Activity Evaluation to provide feedback for future programming.
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 5 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.

Target Audience

This article is intended for primary care clinicians, endocrinologists, orthopedists, and other specialists who care for patients at risk for osteoporosis.

Goal

The goal of this activity is to provide medical news to primary care clinicians and other healthcare professionals in order to enhance patient care.

Accreditation Statements

For Physicians

Medscape

Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this educational activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Medscape Medical News has been reviewed and is acceptable for up to 200 Prescribed credits by the American Academy of Family Physicians. AAFP accreditation begins 09/01/06. Term of approval is for 1 year from this date. This activity is approved for 0.25 Prescribed credits. Credit may be claimed for 1 year from the date of this activity. AAFP credit is subject to change based on topic selection throughout the accreditation year.

AAFP Accreditation Questions


For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity: CME@medscape.net. For technical assistance, contact CME@webmd.net.

For Nurses

This Activity is sponsored by Medscape Continuing Education Provider Unit: Medscape is an approved provider of continuing nursing education by the New York State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.

Approved for 0.3 contact hour(s) of continuing education for RNs and NPs; None of these credits is in the area of pharmacology.

Provider Number: 6FDKKC-PRV-05


Authors and Disclosures

As an organization accredited by the ACCME, Medscape, LLC requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.

News Author

Laurie Barclay, MD
is a freelance reviewer and writer for Medscape.

Disclosure: Laurie Barclay, MD, has disclosed no relevant financial relationships.

CME Author

Charles P Vega, MD
Associate Professor, Residency Director, Department of Family Medicine, University of California, Irvine

Disclosure: Charles Vega, MD, FAAFP, has disclosed that he has received grants for educational activities from Pfizer.

About News CME

News CME is designed to keep physicians and other healthcare professionals abreast of current research and related clinical developments that are likely to affect practice, as reported by the Medscape Medical News group. Send comments or questions about this program to cmenews@medscape.net.
Medscape Medical News 2006. ©2006 Medscape

Legal Disclaimer

The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.
{ParagraphsSidebar}